These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 173766

  • 1. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J, Casaretto A, Albers J.
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [Abstract] [Full Text] [Related]

  • 2. Lipid relation ships in dialysis and renal transplant patients.
    Nicholls AJ, Cumming AM, Catto GR, Edward N, Engeset J.
    Q J Med; 1981 Jan; 50(198):149-60. PubMed ID: 7029600
    [Abstract] [Full Text] [Related]

  • 3. Serum lipid and lipoprotein concentrations in chronic uremia.
    Norbeck HE, Orö L, Carlson LA.
    Acta Med Scand; 1976 Jan; 200(6):487-92. PubMed ID: 189577
    [Abstract] [Full Text] [Related]

  • 4. Relation of high plasma triglyceride levels associated with obesity and regional adipose tissue distribution to plasma lipoprotein-lipid composition in premenopausal women.
    Després JP, Moorjani S, Tremblay A, Ferland M, Lupien PJ, Nadeau A, Bouchard C.
    Clin Invest Med; 1989 Dec; 12(6):374-80. PubMed ID: 2612090
    [Abstract] [Full Text] [Related]

  • 5. Lipoprotein particle abnormalities and the impaired lipolysis in renal insufficiency.
    Lee DM, Knight-Gibson C, Samuelsson O, Attman PO, Wang CS, Alaupovic P.
    Kidney Int; 2002 Jan; 61(1):209-18. PubMed ID: 11786103
    [Abstract] [Full Text] [Related]

  • 6. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
    Witztum JL, Schonfeld G, Weidman SW.
    J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein-apolipoprotein changes in renal transplant recipients: a 2-year follow-up.
    Cassader M, Ruiu G, Gambino R, Alemanno N, Triolo G, Pagano G.
    Metabolism; 1991 Sep; 40(9):922-5. PubMed ID: 1895957
    [Abstract] [Full Text] [Related]

  • 8. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R, Frey F, Flury W, Klose G, Greten H.
    N Engl J Med; 1977 Dec 22; 297(25):1362-6. PubMed ID: 200841
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein spectrum analysis of uremic patients maintained on chronic hemodialysis.
    Felts JM, Zacherle B, Childress G.
    Clin Chim Acta; 1979 Apr 02; 93(1):127-34. PubMed ID: 219971
    [Abstract] [Full Text] [Related]

  • 10. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA.
    Acta Med Scand; 1978 Apr 02; 204(3):211-8. PubMed ID: 211802
    [No Abstract] [Full Text] [Related]

  • 11. Lipoprotein profile in dialysis and transplant patients.
    Lau YK, Woo KT, Lim CH.
    Singapore Med J; 1985 Apr 02; 26(2):193-7. PubMed ID: 3898396
    [No Abstract] [Full Text] [Related]

  • 12. Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis.
    Daubresse JC, Lerson G, Plamteux G, Rorive G, Luyckx AS, Lefebvre PJ.
    Eur J Clin Invest; 1976 Mar 31; 6(2):159-66. PubMed ID: 177295
    [Abstract] [Full Text] [Related]

  • 13. Changes in the composition of plasma lipoproteins in the chronic uremic rat.
    Barry LE, Tan MH.
    Atherosclerosis; 1990 Dec 31; 85(2-3):139-50. PubMed ID: 2102077
    [Abstract] [Full Text] [Related]

  • 14. Concentration and composition of human serum lipoproteins at birth.
    Hardell LI, Carlson LA.
    Clin Chim Acta; 1978 Dec 15; 90(3):285-94. PubMed ID: 215351
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppression enhances atherogenicity of lipid profile after transplantation.
    Quaschning T, Mainka T, Nauck M, Rump LC, Wanner C, Krämer-Guth A.
    Kidney Int Suppl; 1999 Jul 15; 71():S235-7. PubMed ID: 10412786
    [Abstract] [Full Text] [Related]

  • 16. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR, Goldstein JL, Schrott MG, Motulsky AG, Bierman EL.
    J Clin Invest; 1973 Jul 15; 52(7):1569-77. PubMed ID: 4352458
    [Abstract] [Full Text] [Related]

  • 17. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
    Weltman A, Despres JP, Clasey JL, Weltman JY, Wideman L, Kanaley J, Patrie J, Bergeron J, Thorner MO, Bouchard C, Hartman ML.
    Metabolism; 2003 Jan 15; 52(1):73-80. PubMed ID: 12524665
    [Abstract] [Full Text] [Related]

  • 18. Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
    Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H.
    Atherosclerosis; 1997 Jun 15; 131(2):229-36. PubMed ID: 9199276
    [Abstract] [Full Text] [Related]

  • 19. Glucocorticoids and triglyceride transport: effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat.
    Bagdade JD, Yee E, Albers J, Pykalisto OJ.
    Metabolism; 1976 May 15; 25(5):533-42. PubMed ID: 177840
    [Abstract] [Full Text] [Related]

  • 20. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA, Ylikahri R, Huttunen JK.
    Proc R Soc Med; 1976 May 15; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.